公开(公告)号：US20040137041A1

公开(公告)日：2004-07-15

申请号：US10730920

申请日：2003-12-10

申请人： JAKWANG CO., LTD.

发明人： Hyung Ja You ,  Sang Bong Seo

IPC分类号： A61K035/80 ,  C08B037/08 ,  A61K009/70

CPC分类号： C08L5/08 ,  A61K8/0208 ,  A61K8/736 ,  A61K9/006 ,  A61K36/03 ,  A61K36/04 ,  A61K36/28 ,  A61K47/36 ,  A61Q19/00 ,  C08B37/003 ,  A61K2300/00

摘要： The present invention relates to water-soluble natural film and its preparing method. More particularly, the present invention relates to water-soluble natural film manufactured by dissolving as an active ingredient a water-soluble chitosan prepared in such a manner that chitin/chitosan decomposed with lysozyme is rinsed with ethanol, subjected to electric adjustment and sonication in a saline solution and to ion-exchange to obtain water-soluble null-glucosamine fibrin followed by nano-sized coating the null-glucosamine fibrin with immunoglobulin (null-globulin), and seaweeds and functional ingredients in distilled water and gelatinating. The water-soluble natural film according to the present invention, unlike the conventional film containing chitosan, comprises, at a predetermined content ratio, chitosan with improved water solubility and immunity, seaweeds and functional ingredients. Therefore, it imparts elasticity to matrix of a film to enable film molding with convenience and renders more compatibility to human body due to natural materials as its active ingredients, eliciting more favorable feeling when taken in. In particular, the film composition itself is processed to form a film with a desired thickness and size or is coated on a conventional biodegradable resin film, being applicable to a film in preparing an oral cleaning agent with immediate effect and a food packaging material.

摘要翻译： 本发明涉及水溶性天然膜及其制备方法。 更具体地说，本发明涉及通过将以溶菌酶分解的壳多糖/壳聚糖用乙醇冲洗的水溶性壳聚糖作为活性成分溶解而制造的水溶性天然膜，用乙醇冲洗，进行电调节和超声处理 盐水溶液和离子交换以获得水溶性β-葡糖胺纤维蛋白，然后用免疫球蛋白（γ-球蛋白）纳米尺寸涂布β-葡糖胺纤维蛋白，并将海藻和功能成分在蒸馏水中凝胶化。 根据本发明的水溶性天然膜与常规含有壳聚糖的膜不同，含有预定含量的具有改善的水溶性和免疫性，海藻和功能成分的壳聚糖。 因此，由于天然材料作为活性成分，因此赋予膜的基质赋予弹性，能够方便地进行成膜，并且由于天然材料的活性成分而使人体更容易相容，因此在摄取时引起更好的感觉。特别地，将膜组合物本身加工成 形成具有所需厚度和尺寸的膜，或涂覆在常规的可生物降解树脂膜上，适用于制备立即口服清洁剂的膜和食品包装材料。

公开(公告)号：US20030190327A1

公开(公告)日：2003-10-09

申请号：US10404058

申请日：2003-04-02

发明人： Marie-Christine Seguin

IPC分类号： A61K035/80

CPC分类号： A61Q19/08 ,  A61K8/44 ,  A61K8/64 ,  A61K8/9706 ,  A61K36/02 ,  A61K36/04 ,  A61K38/05 ,  A61Q19/00 ,  A61Q19/06

摘要： The present invention relates to an algal adduct of the citrullinylarginine natural dipeptide as well as to its dermatological use and the use of chemical analogs issued from the same dipeptide displaying no toxic potential, as skin and phanera care and treatment agents, the said analogs having the following general formula (I) 1 in which: R1 represents an acyl or acycloxy radical, R2 represents a hydroxyl, amine, alkylamine or alcoxy radical, R3 represents a hydrogen atom or a hydroxyl radical.

摘要翻译： 本发明涉及瓜氨酸精氨酸天然二肽的藻类加合物以及其皮肤病学用途以及使用由不具有毒性潜力的相同二肽发出的化学类似物作为皮肤和香精护理和治疗剂，所述类似物具有 以下通式（I），其中：R1表示酰基或酰基氧基，R2表示羟基，胺，烷基胺或烷氧基，R3表示氢原子或羟基。

公开(公告)号：US20030100877A1

公开(公告)日：2003-05-29

申请号：US09993884

申请日：2001-11-27

发明人： Carol L. Erdman

IPC分类号： A61K035/80 ,  A61F013/20 ,  A61K035/78

CPC分类号： A61F13/539 ,  A61F13/15577 ,  A61F13/8405 ,  A61F2013/53908 ,  A61K8/0208 ,  A61K8/97 ,  A61L15/18 ,  A61L15/34 ,  A61L15/46 ,  A61L2300/102 ,  A61L2300/30 ,  A61L2300/428 ,  A61Q19/00

摘要： An absorbent garment comprising skin wellness ingredients is disclosed, where the skin wellness ingredients are incorporated into an adhesive used in the assembly of the garment. By incorporating the skin wellness ingredients into the adhesive, the skin wellness ingredients can be precisely placed on those portions of the absorbent garment where at least perceived skin care benefits for the wearer's skin are desired.

摘要翻译： 公开了一种包含皮肤保健成分的吸收性服装，其中将皮肤健康成分并入用于衣服组装中的粘合剂中。 通过将皮肤保健成分掺入粘合剂中，可以将皮肤保健成分精确地放置在吸收性衣服的那些部分上，其中至少感觉到的皮肤护理有利于穿着者的皮肤。

公开(公告)号：US20030086944A1

公开(公告)日：2003-05-08

申请号：US09947898

申请日：2001-09-06

发明人： Gutierrez Gilles

IPC分类号： A61K035/80

CPC分类号： C12Q1/025 ,  A61K36/03 ,  Y10S435/946

摘要： The present invention relates to the field of chemistry and more particularly to that of plant chemistry. Its specific aim is a process for obtaining powders or extracts from the alga Padina pavonica, titrated with active principles by means of a coefficient of equivalence with estradiol, which consists of dosing the extract or the powder of Padina pavonica using a method in which osteoblasts are cultivated in a medium rich in calcium ions, an analysis is made of the calcium fixed by the cells of the extracellular matrix in the presence or absence of agents antagonistic to the fixing of calcium, and the results are expressed either in arbitrary or international units in relation to a reference standard or by reference to the known activity of fixed doses of estradiol or of any other agent favouring the fixing of calcium.

摘要翻译： 本发明涉及化学领域，更具体地涉及植物化学领域。 其具体目标是从藻类Padina pavonica获得粉末或提取物的方法，用活性成分通过与雌二醇相当的系数滴定，该方法包括使用成骨细胞的方法给予提取物或粉末的Padina pavonica 在富含钙离子的培养基中培养，在存在或不存在拮抗钙固定的药剂存在下，分析由细胞外基质的细胞固定的钙，结果以任意或国际单位表示 与参考标准的关系，或通过参考固定剂量的雌二醇或有利于固定钙的任何其他药剂的已知活性。

公开(公告)号：US20030078304A1

公开(公告)日：2003-04-24

申请号：US10239192

申请日：2002-09-27

发明人： Tove Andersson ,  Sven Pettersson

IPC分类号： A61K031/12 ,  A61K035/80

CPC分类号： A61K36/05 ,  A61K31/12 ,  A61K31/122 ,  A61K2300/00

摘要： A method of inhibiting the expression of inflammatory cytokines and chemokines in an animal or man, is disclosed. The method comprises administration to said animal or man of at least one type of xanthophyll, e.g. astaxanthin, in an amount inhibiting the expression of inflammatory cytokines and chemokines in said animal or man. Use of at least one type of xanthophyll, such as astaxanthin, for the preparation of a medicament for the prophylactic and/or therapeutic inhibition of the expression of inflammatory cytokines and chemokines in an animal or man, is described. Further, a commercial package containing a medicament comprising at least one type of xanthophyll, e.g. astaxanthin, and written and/or data carrier instructions for administration to an animal or man of the medicament for the prophylactic and/or therapeutic inhibition of the express of inflammatory cytokines and chemokines, is disclosed.

摘要翻译： 公开了抑制动物或人类中炎性细胞因子和趋化因子表达的方法。 所述方法包括向所述动物或人施用至少一种类型的叶黄素，例如。 虾青素，其抑制所述动物或人中炎性细胞因子和趋化因子的表达。 描述了使用至少一种类型的叶黄素，例如虾青素，用于制备用于预防和/或治疗性抑制动物或人类中炎性细胞因子和趋化因子表达的药物。 此外，包含含有至少一种类型的叶黄素的药物的商业包装， 公开了用于对动物或人的用于预防和/或治疗性抑制炎性细胞因子和趋化因子的表达的药物的书写和/或数据载体说明书。

公开(公告)号：US20020022049A1

公开(公告)日：2002-02-21

申请号：US09948654

申请日：2001-09-10

发明人： Vivien Gore Allen ,  Kevin R. Pond

IPC分类号： A61K035/80

CPC分类号： A61K36/02 ,  A23K10/30 ,  A23K20/10 ,  A23K50/00 ,  A23K50/10 ,  A23K50/20 ,  A23K50/75 ,  A61K36/03 ,  A61K36/04 ,  Y10S514/807 ,  Y10S514/885 ,  A61K2300/00

摘要： Seaweed supplement is included in diet of mammals and poultry to enhance immune response. In one embodiment, pasture forage is treated with seaweed supplement. When cattle or lambs are grazed on seaweed supplement treated endophyte-infected forage, immune function is preserved or depressed immune function is reversed. The enhanced immune function continues to the feedlot finishing phase even though no seaweed supplement is fed in that phase. In an independently inventive embodiment, seaweed supplement is administered to pigs exposed to PRRS disease to impart resistance to said disease and improve performance. In still another independently inventive embodiment, seaweed supplement is administered to lactating mares prior to weaning to mitigate the stress of weaning.

公开(公告)号：US20020009472A1

公开(公告)日：2002-01-24

申请号：US09874252

申请日：2001-06-06

发明人： Yoichiro Takekoshi ,  Tomoya Takahashi ,  Toshio Oouma

IPC分类号： A61K007/00 ,  A61K035/66 ,  A61K035/68 ,  A61K035/70 ,  A01N063/02 ,  A61K035/76 ,  A61K035/80 ,  A61K035/72 ,  A61K035/74

CPC分类号： A61Q19/00 ,  A61K8/0212 ,  A61K8/44 ,  A61K8/4913 ,  A61K8/64 ,  A61K8/65 ,  A61K8/671 ,  A61K8/673 ,  A61K8/675 ,  A61K8/676 ,  A61K8/678 ,  A61K8/68 ,  A61K8/73 ,  A61K8/731 ,  A61K8/735 ,  A61K8/9706 ,  A61Q1/06 ,  A61Q5/00 ,  A61Q19/08

摘要： The present invention provides cosmetics comprising (1) hydroxyproline, an N-acylated hydroxyproline derivative or a salt thereof and (2) at least one component selected from the group consisting of water-soluble vitamins, oil-soluble vitamins, high molecular peptides, high molecular polysaccharides, sphingolipids and seaweed extracts.

摘要翻译： 本发明提供了包含（1）羟脯氨酸，N-酰化羟脯氨酸衍生物或其盐的化妆品和（2）至少一种选自水溶性维生素，油溶性维生素，高分子量肽，高分子量肽 分子多糖，鞘脂和海藻提取物。

公开(公告)号：US20010033843A1

公开(公告)日：2001-10-25

申请号：US09838439

申请日：2001-04-19

发明人： Anton Scherer ,  Peter Schwind

IPC分类号： A61K035/80 ,  A61K038/44

CPC分类号： A61K35/748 ,  A61L12/082 ,  A61L12/126 ,  A61L12/14 ,  Y10S134/901

摘要： The present invention is directed to an ophthalmic product comprising, as a coloring agent, the extract of an alga. A preferred class of alga the extract of which is useful in the present invention is blue alga (Spirulina type), more preferred it is Japanese blue alga (Spirulina platensis). The ophthalmic product is preferably a contact lens care product.

摘要翻译： 本发明涉及一种眼科产品，其包含藻类提取物作为着色剂。 其中提取物在本发明中有用的一类优选的藻类是蓝藻（螺旋藻型），更优选的是日本蓝藻（Spirulina platensis）。 眼用产品优选为隐形眼镜护理产品。

公开(公告)号：US20040253269A1

公开(公告)日：2004-12-16

申请号：US10813388

申请日：2004-03-30

申请人： PARTICIPATIONS INDUSTRIELLES ET FINANCIERES S.A. ,  TEXINFINE S.A.

发明人： Gilles Gutierrez ,  Mostafa Serrar

IPC分类号： A61K035/80

CPC分类号： A61Q19/08 ,  A61K8/9706 ,  A61K36/03

摘要： The invention relates to the field of cosmetology, more specifically to novel topical compositions containing an alga extract. The aim of the invention is to use an alga extract from the Dictyotal family in the production of compositions containing an alga extract as an active ingredient which results in the maturation of Keratinocytes and in the increase of desmosomial proteins for use by topical administration on the skin, mucuous membranes and teguments. The invention is used on parts of the body that are subjected to problems caused by ageing.

摘要翻译： 本发明涉及美容领域，更具体地涉及含有藻类提取物的新型局部组合物。 本发明的目的是使用来自Dictytal家族的藻类提取物生产含有藻类提取物作为活性成分的组合物，其导致角质形成细胞的成熟和通过局部施用于皮肤上使用的体外蛋白质的增加 ，粘膜和牙膏。 本发明用于身体受老化所引起的问题的部位。

公开(公告)号：US20040253227A1

公开(公告)日：2004-12-16

申请号：US10725610

申请日：2003-12-02

发明人： Kenneth A. Martin ,  Teresa Leigh Barr

IPC分类号： A61K038/46 ,  A61K035/80 ,  A61K047/00

CPC分类号： A23L33/155 ,  A23L5/00 ,  A23L7/00 ,  A23L21/00 ,  A23L29/30 ,  A23L33/10 ,  A23L33/105 ,  A23L33/125 ,  A23L33/15 ,  A23L33/28 ,  A23V2002/00 ,  A61K31/355 ,  A61K31/375 ,  A61K31/445 ,  A61K31/7008 ,  A61K31/737 ,  A61K36/48 ,  A61K36/68 ,  A61K36/87 ,  A61K36/899 ,  A61K2300/00 ,  A23V2250/708 ,  A23V2250/7046 ,  A23V2250/204 ,  A23V2250/21 ,  A23V2250/2124

摘要： The perioperative multivitamin protein additive for promoting an anabolic state in a person, is made of from about 250 mg to about 2500 mg a digestive enzyme, such as bromelain, pepsin, amylase, protease, lipase, cellulase, lactase, alpha-g, glucoamylase, invertase, malt diastase, pectinase, xylanase, bromelain, betain, and trypsin, or combinations thereof; from about 50 mg to about 2500 mg of an amino acid; from about 200 mg to about 2000 mg of a sea plant; from about 10 mg to about 8000 mg of a flavoring; from 100 mg to 2500 mg o Vitamin A, Vitamin B, Vitamin D, Vitamin E, Vitamin K and calcium, complexes thereof, and combinations thereof; and from about 1000 mg to about 9000 mg of a fiber. The perioperative multivitamin protein additive can be added to an ingestible liquid in order to form a perioperative multivitamin protein beverage.

摘要翻译： 用于促进人体中合成代谢状态的围手术期多种维生素蛋白质添加剂由约250mg至约2500mg的消化酶，例如菠萝蛋白酶，胃蛋白酶，淀粉酶，蛋白酶，脂肪酶，纤维素酶，乳糖酶，α-g，葡糖淀粉酶 ，转化酶，麦芽淀粉酶，果胶酶，木聚糖酶，菠萝蛋白酶，甜菜碱和胰蛋白酶，或其组合; 约50mg至约2500mg氨基酸; 从约200mg到约2000mg的海洋植物; 约10mg至约8000mg调味剂; 从100mg至2500mg维生素A，维生素B，维生素D，维生素E，维生素K和钙，其复合物及其组合; 和约1000mg至约9000mg的纤维。 围手术期多种维生素蛋白质添加剂可添加到可摄入液体中，以形成围手术期多种维生素蛋白饮料。